LCDX vs ABT: Which Stock is Better?
Side-by-side comparison of Caliber Imaging & Diagnostics Inc and Abbott Laboratories in 2026
LCDX
Caliber Imaging & Diagnostics Inc
$0.00
ABT
Abbott Laboratories
$96.81
Key Metrics Comparison
| Metric | LCDX | ABT | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $168.23B | ABT |
| P/E Ratio | N/A | 26.74 | ABT |
| EPS (TTM) | $N/A | $3.62 | ABT |
| Revenue Growth | -0.2% | 0.1% | ABT |
| Gross Margin | 15.5% | 56.5% | ABT |
Analyze LCDX
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCDX or ABT a better investment?
Comparing LCDX and ABT: Caliber Imaging & Diagnostics Inc has a market cap of $0.01M while Abbott Laboratories has $168.23B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCDX and ABT?
LCDX (Caliber Imaging & Diagnostics Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCDX or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCDX or ABT?
ABT has higher revenue growth at 0.1% vs -0.2% for LCDX.
Which company is more profitable: LCDX or ABT?
Abbott Laboratories (ABT) has higher gross margins at 56.5% compared to 15.5% for LCDX.
Which is the larger company: LCDX or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $168.23B compared to $0.01M for LCDX.
Should I buy LCDX or ABT in 2026?
Both LCDX and ABT have investment merit. LCDX trades at $0.00 while ABT trades at $96.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCDX and ABT stock?
Key differences: Market Cap ($0.01M vs $168.23B), P/E Ratio (N/A vs 26.7x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (15.5% vs 56.5%).